Use of nepafenac (Nevanac®)in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections

Eric Chen, Matthew S. Benz, Richard H. Fish, David M. Brown, Tien P. Wong, Rosa Y. Kim, James C. Major

Research output: Contribution to journal › Review article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Use of nepafenac (Nevanac®)in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections'. Together they form a unique fingerprint.

Medicine & Life Sciences